This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

Species in Maple Life Science™ / Lactobacillus Helveticus

  1. lactobacillus helveticus

Infer Impacts Maple Life Science™ / Lactobacillus Helveticus on Symptoms

Probiotic:
Symptom:

Not sufficient information to infer impact

Bacteria Impacts of Maple Life Science™ / Lactobacillus Helveticus

If you find any studies of this specific probiotic impacting other bacteria, please email ken/at/lassesen.com with the URI

This table is estimated from the impact of EACH species in the probiotics reported in clinical studies. In some cases, one species will increase and another decrease. Often, all of the species have similar (or no impact).

Genus Level Only Listed
BacteriaIncrease %Decrease %
Acetatifactor 0 100
Acidipropionibacterium 0 100
Acutalibacter 0 100
Akkermansia 0 100
Anaeromicropila 0 100
Bacillus 0 100
Bacteroides 33 66
Bifidobacterium 50 50
Butyribacter 100 0
Campylobacter 0 100
Citrobacter 0 100
Clostridium 100 0
Enterococcus 100 0
Escherichia 0 100
Faecalibaculum 100 0
Faecalimonas 0 100
Falcatimonas 0 100
Flavonifractor 0 100
Gardnerella 0 100
Kineothrix 0 100
Klebsiella 0 100
Kluyvera 0 100
Lachnoclostridium 0 100
Lacrimispora 0 100
Lactobacillus 100 0
Murimonas 0 100
Prevotella 0 100
Propionibacterium 0 100
Proteus 0 100
Proteus 0 100
Pseudomonas 0 100
Roseburia 100 0
Salmonella 0 100
Shigella 0 100
Staphylococcus 0 100
Streptococcus 0 100
Turicibacter 0 100
Yersinia 0 100

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]